Anika Therapeutics (ANIK) Competitors $8.94 +0.29 (+3.29%) As of 09:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIK vs. ANVS, OSUR, CERS, UTMD, WST, COO, ALGN, MMSI, ICUI, and XRAYShould you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Annovis Bio (ANVS), OraSure Technologies (OSUR), Cerus (CERS), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "medical" sector. Anika Therapeutics vs. Its Competitors Annovis Bio OraSure Technologies Cerus Utah Medical Products West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Anika Therapeutics (NASDAQ:ANIK) and Annovis Bio (NYSE:ANVS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations. Does the media favor ANIK or ANVS? In the previous week, Anika Therapeutics and Anika Therapeutics both had 2 articles in the media. Anika Therapeutics' average media sentiment score of 0.89 beat Annovis Bio's score of 0.00 indicating that Anika Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anika Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Annovis Bio 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer ANIK or ANVS? Anika Therapeutics currently has a consensus target price of $18.00, suggesting a potential upside of 101.23%. Annovis Bio has a consensus target price of $17.33, suggesting a potential upside of 631.06%. Given Annovis Bio's higher probable upside, analysts plainly believe Annovis Bio is more favorable than Anika Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anika Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Annovis Bio 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has higher valuation and earnings, ANIK or ANVS? Annovis Bio has lower revenue, but higher earnings than Anika Therapeutics. Anika Therapeutics is trading at a lower price-to-earnings ratio than Annovis Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnika Therapeutics$119.91M1.08-$56.38M-$4.15-2.16Annovis BioN/AN/A-$24.59M-$2.04-1.16 Is ANIK or ANVS more profitable? Annovis Bio has a net margin of 0.00% compared to Anika Therapeutics' net margin of -48.99%. Anika Therapeutics' return on equity of -10.97% beat Annovis Bio's return on equity.Company Net Margins Return on Equity Return on Assets Anika Therapeutics-48.99% -10.97% -8.51% Annovis Bio N/A -206.01%-158.26% Which has more volatility and risk, ANIK or ANVS? Anika Therapeutics has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500. Comparatively, Annovis Bio has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500. Do insiders & institutionals have more ownership in ANIK or ANVS? 91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 15.8% of Annovis Bio shares are held by institutional investors. 9.6% of Anika Therapeutics shares are held by company insiders. Comparatively, 20.8% of Annovis Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryAnnovis Bio beats Anika Therapeutics on 8 of the 15 factors compared between the two stocks. Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANIK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIK vs. The Competition Export to ExcelMetricAnika TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$130.41M$3.13B$5.78B$10.27BDividend YieldN/A2.37%5.74%4.64%P/E Ratio-2.1821.3676.5826.99Price / Sales1.08423.34512.47164.74Price / Cash90.7945.3237.1760.63Price / Book0.859.6913.586.37Net Income-$56.38M-$52.92M$3.29B$271.62M7 Day Performance3.17%2.19%1.59%2.53%1 Month Performance4.13%8.96%6.84%9.42%1 Year Performance-64.73%10.84%78.54%30.19% Anika Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIKAnika Therapeutics4.3814 of 5 stars$8.95+3.3%$18.00+101.2%-64.9%$130.41M$119.91M-2.18300ANVSAnnovis Bio2.1963 of 5 stars$2.42-2.6%$17.33+617.7%-71.8%$48.33MN/A-1.183OSUROraSure Technologies2.213 of 5 stars$3.23-2.4%$3.00-7.1%-23.4%$242.08M$185.83M-4.82840Positive NewsCERSCerus2.9894 of 5 stars$1.20-2.4%$3.50+191.7%-27.0%$235.79M$180.27M-12.00290Positive NewsShort Interest ↓UTMDUtah Medical Products2.3743 of 5 stars$62.49+0.3%N/A-5.6%$199.75M$40.90M16.71180Positive NewsWSTWest Pharmaceutical Services4.9908 of 5 stars$257.73+1.7%$318.56+23.6%-17.5%$18.23B$2.89B38.5810,600Positive NewsCOOCooper Companies4.4583 of 5 stars$65.48-1.8%$86.64+32.3%-39.2%$13.26B$3.90B32.2616,000Trending NewsBuyback AnnouncementAnalyst RevisionGap UpALGNAlign Technology4.9356 of 5 stars$131.06-0.4%$215.00+64.0%-47.6%$9.54B$4.00B22.1020,945Positive NewsMMSIMerit Medical Systems4.7788 of 5 stars$82.93-3.0%$107.00+29.0%-14.8%$5.07B$1.36B42.107,400Positive NewsHigh Trading VolumeICUIICU Medical4.4628 of 5 stars$132.17+1.4%$181.00+36.9%-24.5%$3.22B$2.38B-86.9515,000Positive NewsXRAYDENTSPLY SIRONA4.9428 of 5 stars$13.54+0.1%$18.64+37.6%-49.8%$2.70B$3.79B-2.8614,000Positive News Related Companies and Tools Related Companies Annovis Bio Alternatives OraSure Technologies Alternatives Cerus Alternatives Utah Medical Products Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANIK) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
